Durmus et al37 2014 USA PS 22 Negative flexible laryngopharyngoscopy and imaging. Then PETCT (some positive). TORS IL tonsillectomy, IL TBM (variable extent) 77.3% (17/22) 17.6% (3/17) 59.1% (10/17) 17.6% (2/3 PT, 1/3 BOT) BL. 80% HPV, 95% P16 Together with PE, directed Biopsy and PET-CT, TORS valuable option ID and Tx primary tumour sites
Patel et al38
2013
USA
RS
47
Ex, flexible scope, CT/MRI and PET. PE directed Biopsy, TORS UL or BL tonsillectomy, UL or BL TBM
72.3% (34/47) (TORS alone)
58.8% (20/34)
38.2% (13/34)
2.9% (1/34 BOT and palatine tonsil) synchronous
76.5% (28/34) positive
10.6% (5/47): Bleeding (4/5: 8.5%) with 50% RTT and tongue swelling (1/5).
TORS useful approach id and Tx primary site HNSCCUP